Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ATRA
$8.09
-4.94%
ATRA · Atara Biotherapeutics, Inc.
$8.09
-0.42 (-4.94%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$81.21M
Shares
10.04M
All earnings calls
Earnings call · FY2020 Q3
Atara Biotherapeutics, Inc. Q3 FY2020 Earnings Call
Atara Biotherapeutics, Inc. Q3 FY2020 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Net income
-$74.35M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2020 · complete as-filed document